论文部分内容阅读
目的对腹腔镜手术治疗子宫肌瘤临床效果卫生经济学进行评价。方法回顾分析2013年4月至2014年4月收治的子宫肌瘤患者96例的临床资料,观察患者治疗情况,并按照卫生经济学的成本-效果分析法对治疗成本进行分析。结果腹腔镜组手术出血量少于对照组,术后住院时间、恢复工作时间均短于对照组,但手术时间长于对照组(P均<0.05);腹腔镜组术后3个月症状改善有效率为83.33%,明显高于对照组的59.26%(P<0.05),腹腔镜组术后6个月症状改善有效率为100.00%,明显高于对照组的88.89%(P<0.05);腹腔镜组直接医疗成本高于对照组(P<0.01),直接非医疗成本低于对照组(P<0.05),误工费低于对照组(P<0.01),总成本略高于对照组,但差异无统计学意义(P>0.05)。结论腹腔镜下行子宫肌瘤剔除术与开腹子宫肌瘤剔除术的治疗总成本差别不大,但腹腔镜组的治疗效果明显优于对照组。
Objective To evaluate the clinical economics of laparoscopic surgery for uterine fibroids. Methods The clinical data of 96 patients with uterine fibroids admitted from April 2013 to April 2014 were retrospectively analyzed. The treatment of patients with uterine fibroids was observed. The treatment cost was analyzed according to the cost-effectiveness analysis method of health economics. Results The amount of bleeding in laparoscopic group was less than that in control group. The postoperative hospital stay and recovery time were shorter than those in control group, but the operation time was longer than that in control group (all P <0.05). The symptom improvement in laparoscopic group at 3 months The effective rate was 83.33%, significantly higher than that of the control group (59.26%, P <0.05). The effective rate of symptom improvement at 6 months after laparoscopic surgery was 100.00%, which was significantly higher than that of the control group (88.89%, P <0.05) The direct medical cost of the mirror group was higher than that of the control group (P <0.01), the direct non-medical cost was lower than that of the control group (P <0.05), and the loss of working time was lower than that of the control group (P <0.01) The difference was not statistically significant (P> 0.05). Conclusion The total cost of laparoscopic myomectomy and open myomectomy is not different, but the treatment effect of laparoscopic group is obviously better than that of control group.